SHORT TERM EFFECTS OF MEDICINAL CANNABIS ON SPASTICITY IN MULTIPLE SCLEROSIS

药用大麻对多发性硬化症痉挛的短期影响

• 批准号: 7374158
• 负责人: JODY COREY-BLOOM
• 金额: $ 1.52万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7374158
• 关键词: Cannabis; multiple sclerosis; placebos; smoking; stress

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Assess the safety and efficacy of smoked medicinal cannabis versus placebo over 17 days in multiple sclerosis patients with spasticity. Short term safety, particularly in terms of neuropsychiatric side effects, will be stressed. Spasticity ratings, cognitive ratings and additional global measures will be obtained before and after treatment with either placebo or active product for 3 days.

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。评估吸烟药用大麻与安慰剂在多发性硬化症痉挛患者17天内的安全性和有效性。将强调短期安全性，特别是在神经精神副作用方面。在使用安慰剂或活性产品治疗3天之前和之后，将获得痉挛程度评级、认知评级和其他全球测量。